Rafael Holdings, Inc. (RFL) stock
RFLNYSEPharmaceutical PreparationsFiscal year ends July 31
$0.92+0.02 (+2.19%)
Close on Nov 20, 2026Market cap $47.99MP/E –Yield –
Rafael free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Rafael's free cash flow for the twelve months ending Jul 31, 2026 was -$29.99M. For fiscal 2026 it was -$29.99M. The highest annual figure on record is -$1.48M in fiscal 2016.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jul 31, 2026 | -$29.99M | – |
| FY2025 | Jul 31, 2025 | -$18.93M | – |
| FY2024 | Jul 31, 2024 | -$7.95M | – |
| FY2022 | Jul 31, 2022 | -$26.08M | – |
| FY2021 | Jul 31, 2021 | -$15.81M | – |
| FY2020 | Jul 31, 2020 | -$5.20M | – |
| FY2019 | Jul 31, 2019 | -$3.53M | – |
| FY2018 | Jul 31, 2018 | -$2.53M | – |
| FY2017 | Jul 31, 2017 | -$3.44M | – |
| FY2016 | Jul 31, 2016 | -$1.48M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jul 31, 2026 | -$8.37M | – |
| Q3 FY2026CQ1 2026 | Apr 30, 2026 | -$7.28M | – |
| Q4 FY2025CQ2 2025 | Jul 31, 2025 | -$10.38M | – |
| Q3 FY2025CQ1 2025 | Apr 30, 2025 | -$3.19M | – |
| Q2 FY2025CQ4 2024 | Jan 31, 2025 | -$2.32M | – |
| Q1 FY2025CQ3 2024 | Oct 31, 2024 | -$3.05M | – |
| Q4 FY2024CQ2 2024 | Jul 31, 2024 | -$2.90M | – |
| Q3 FY2024CQ1 2024 | Apr 30, 2024 | -$375.00K | – |
| Q4 FY2022CQ2 2022 | Jul 31, 2022 | -$1.90M | – |
| Q3 FY2022CQ1 2022 | Apr 30, 2022 | -$10.37M | – |
| Q2 FY2022CQ4 2021 | Jan 31, 2022 | -$7.31M | – |
| Q1 FY2022CQ3 2021 | Oct 31, 2021 | -$6.50M | – |
| Q4 FY2021CQ2 2021 | Jul 31, 2021 | -$6.95M | – |
| Q3 FY2021CQ1 2021 | Apr 30, 2021 | -$3.13M | – |
| Q2 FY2021CQ4 2020 | Jan 31, 2021 | -$2.93M | – |
| Q1 FY2021CQ3 2020 | Oct 31, 2020 | -$2.80M | – |
| Q4 FY2020CQ2 2020 | Jul 31, 2020 | -$1.73M | – |
| Q3 FY2020CQ1 2020 | Apr 30, 2020 | -$1.11M | – |
| Q2 FY2020CQ4 2019 | Jan 31, 2020 | -$1.10M | – |
| Q1 FY2020CQ3 2019 | Oct 31, 2019 | -$1.26M | – |
| Q4 FY2019CQ2 2019 | Jul 31, 2019 | -$629.00K | – |
| Q3 FY2019CQ1 2019 | Apr 30, 2019 | -$1.95M | – |
| Q2 FY2019CQ4 2018 | Jan 31, 2019 | -$207.00K | – |
| Q1 FY2019CQ3 2018 | Oct 31, 2018 | -$750.00K | – |
| Q4 FY2018CQ2 2018 | Jul 31, 2018 | -$883.00K | – |
| Q3 FY2018CQ1 2018 | Apr 30, 2018 | -$955.00K | – |
| Q2 FY2018CQ4 2017 | Jan 31, 2018 | -$435.00K | – |
| Q1 FY2018CQ3 2017 | Oct 31, 2017 | -$252.00K | – |
| Q4 FY2017CQ2 2017 | Jul 31, 2017 | -$1.38M | – |
| Q3 FY2017CQ1 2017 | Apr 30, 2017 | -$554.00K | – |
See a number that looks wrong?